688189 南新制药
2025/09 - 九个月
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0000
固定资产149,880-8.36%163,557184,895200,731223,585
在建工程5,5251,465.16%3535732401,275
无形资产130,895-8.55%143,135124,284138,006158,413
商誉0--010,84510,84513,569
其他非流动资产173,67426.73%137,043126,928108,614120,846
459,9743.58%444,089447,525458,436517,689

流动资产
货币资金427,810-12.74%490,270665,761713,472730,668
应收账款62,587-68.00%195,598520,669728,193590,813
存货47,548-22.27%61,16730,36627,01561,425
其他流动资产35,97014.87%31,31555,06327,492230,275
573,915-26.27%778,3501,271,8581,496,1721,613,181

流动负债
短期借款148,199-32.08%218,187322,950488,733385,437
应付票据0--00080,000
应付帐款16,754-57.68%39,59139,54837,49676,467
其他流动负债64,705-21.16%82,07565,538122,127132,766
229,659-32.42%339,853428,035648,355674,671
流动资产净值344,256-21.49%438,497843,822847,817938,510
资产总额减流动负债804,230-8.88%882,5861,291,3481,306,2531,456,199

非流动负债
长期借款0--00050,846
应付债券0--0000
其他非流动负债3,669-14.28%4,2805,7689,88111,370
3,669-14.28%4,2805,7689,88162,216

总权益
    实收股本274,4000.00%274,400274,400196,000140,000
    储备项目591,590-10.66%662,1921,029,0961,118,3651,253,197
股东权益865,990-7.54%936,5921,303,4961,314,3651,393,197
非控股权益(65,430)12.26%(58,286)(17,916)(17,993)786